Ozempic for weight loss: separating real results from TikTok hype

What did @anthonyruiz432 actually say?

Honestly? It's hard to tell. The transcript here is largely incoherent, referencing a birthday, winning something, being "part of the ologic world," and making videos "from the inside of the game." None of that maps onto a coherent claim about GLP-1 medications, weight loss, or any health topic. The hashtags mention Ozempic and weight loss, but the actual spoken words don't deliver a medical claim, a personal result, or even a clear narrative arc. We can't quote him on anything specific about semaglutide or weight loss because he didn't say anything specific about either.

This matters because fact-checking a video tagged with #ozempic and #weightloss sets a certain expectation. Viewers scrolling past this clip may absorb the association between this creator and GLP-1 drugs without getting any real information. The hashtag does the work the content doesn't. That's worth flagging on its own.

Does the science back this up?

There's nothing to evaluate here scientifically, because no concrete claim was made. But since viewers landing on a GLP-1-tagged video deserve real context, here's what the evidence actually shows about semaglutide for weight loss.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that adults with obesity who took 2.4mg weekly semaglutide lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% in the placebo group. That's a real, significant finding. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% mean body weight reduction at the highest dose tested. These are not small effects. They represent a genuine shift in what pharmacological weight management can achieve.

But results vary. Baseline weight, adherence, diet, and individual pharmacokinetics all influence outcomes. No medication works the same for everyone, and no TikTok hashtag tells you whether it will work for you.

What did they get wrong (or right)?

This is genuinely unusual territory for a fact-check. Anthony didn't get anything wrong in a medically verifiable sense, because he didn't make a medical claim. He also didn't get anything right in that sense. What he did do is associate himself with the GLP-1 conversation through hashtags, which carries its own kind of influence even when the content is opaque.

The concern isn't misinformation in the traditional sense. It's ambient association. Research on health misinformation on social media (Suarez-Lledo and Alvarez-Galvez, 2021, Journal of Medical Internet Research) has shown that even vague or tangentially related content can shape health perceptions when it appears alongside high-salience hashtags. A viewer who sees #ozempic paired with a personal "weight loss journey" framing may walk away with impressions that were never explicitly stated, and never explicitly fact-checked.

That's not Anthony's fault in any deliberate sense. But it's real, and it's why context matters even when content is unclear.

What should you actually know?

If you found this video because you're researching GLP-1 medications for weight loss, here's what actually matters. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are FDA-approved medications with meaningful clinical evidence behind them. They are not magic. They work best alongside behavioral changes, and they come with side effects, including nausea, vomiting, and in rarer cases, more serious gastrointestinal complications.

Compounded versions of semaglutide have been widely discussed online. The FDA has consistently warned that compounded drugs are not FDA-approved and are not equivalent to brand-name products in terms of verified potency, purity, or efficacy. Do not assume a compounded formulation performs identically to a regulated brand-name drug.

If you are considering a GLP-1 medication, talk to a licensed clinician who can review your full health history. A TikTok hashtag is not a clinical recommendation. Neither is this article. What it is, is an honest account of what the evidence shows and what one video, despite its tags, actually failed to say.